The delta-like ligand 3 targeted therapies market is witnessing significant growth, driven by the rising incidence of small cell lung cancer (SCLC) and neuroendocrine...
BOSTON, June 13, 2025 /PRNewswire/ -- Ratio Therapeutics Inc. (Ratio), a pharmaceutical company employing innovative technologies to develop best-in-class radiopharmaceuticals for cancer treatment and monitoring,...
New 40-person office in Oak Ridge leads the continuing development of Orano's planned multibillion-dollar uranium enrichment facility on restored Manhattan Project property.
OAK RIDGE, Tenn., June...